北交所IPO审核进入收官倒计时！一周四审上会企业均获通过

Core Viewpoint - The Beijing Stock Exchange (BSE) is accelerating its IPO review process, with a focus on the sustainability and authenticity of company performance, as well as the necessity of fundraising projects [1][2]. Group 1: IPO Review Process - The BSE's listing committee held its 46th to 49th review meetings from December 22 to 26, 2025, approving four companies: Ying's Holdings, Longyuan Co., Puan Medical Technology, and New Hengtai New Materials, all meeting the issuance and listing requirements [1]. - Key concerns during the review included the sustainability of performance growth, accuracy of revenue recognition, reasons for declining gross margins, and the authenticity of online sales revenue [1]. Group 2: Company Performance - Ying's Holdings reported revenues of 1.296 billion yuan, 1.758 billion yuan, 1.974 billion yuan, and 1.132 billion yuan from 2022 to the first half of 2025, with net profits of 114 million yuan, 216 million yuan, 190 million yuan, and 136 million yuan [2]. - Longyuan Co. achieved revenues of 519 million yuan, 699 million yuan, 869 million yuan, and 475 million yuan during the same period, with net profits of 97 million yuan, 118 million yuan, 112 million yuan, and 61 million yuan [2]. - New Hengtai and Puan Medical also showed optimistic performance, with New Hengtai's revenues reaching 530 million yuan, 679 million yuan, 774 million yuan, and 384 million yuan, and net profits of 45 million yuan, 101 million yuan, 91.76 million yuan, and 51.35 million yuan [2]. Group 3: Quality of Companies in the Pipeline - As of December 25, 2025, there are 168 companies in the BSE's IPO queue, with only one company projected to be unprofitable in 2024, indicating an overall improvement in the quality of companies seeking to go public [4]. - Among the 168 companies, 50 have net profits exceeding 100 million yuan, accounting for 29.8% of the total [4]. - New companies entering the IPO process, such as Hubei Benxing New Materials, reported revenues of 3.726 billion yuan, 3.606 billion yuan, 4.445 billion yuan, and 2.287 billion yuan from 2022 to the first half of 2025, with net profits of 451 million yuan, 356 million yuan, 389 million yuan, and 199 million yuan [4].